Recent studies have suggested a possible role for presenilin proteins in apoptotic cell death observed in Alzheimer's disease. The mechanism by which presenilin proteins regulate apoptotic cell death is not well understood. Using the yeast two-hybrid system, we previously isolated a novel protein, presenilin-associated protein (PSAP) that specifically interacts with the C terminus of presenilin 1 (PS1), but not presenilin 2 (PS2). Here we report that PSAP is a mitochondrial resident protein sharing homology with mitochondrial carrier protein. PSAP was detected in a mitochondria-enriched fraction, and PSAP immunofluorescence was present in a punctate pattern that colocalized with a mitochondrial marker. More interestingly, overexpression of PSAP caused apoptotic death. PSAP-induced apoptosis was documented using multiple independent approaches, including membrane blebbing, chromosome condensation and fragmentation, DNA laddering, cleavage of the death substrate poly(ADP-ribose) polymerase, and flow cytometry. PSAP-induced cell death was accompanied by cytochrome c release from mitochondria and caspase-3 activation. Moreover, the general caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, which blocked cell death, did not block the release of cytochrome c from mitochondria caused by overexpression of PSAP, indicating that PSAP-induced cytochrome c release was independent of caspase activity. The mitochondrial localization and proapoptotic activity of PSAP suggest that it is an important regulator of apoptosis.
an inherited autosomal dominant disease caused by defects in any of three genes: presenilin 1 (PS1) on chromosome 14, presenilin 2 (PS2) on chromosome 1, and the amyloid precursor protein (APP) on chromosome 21 (for review, see Ref. 2) . The majority of FAD cases have been associated with mutations in PS1 and PS2 (2) . It has been shown that FAD-associated mutations in PS1 and PS2 affect the processing of APP, leading to an increased production of the more amyloidogenic A␤ peptide, both in vivo and in vitro (3) (4) (5) (6) . In addition to their roles in APP processing, roles for PS1 and PS2 in programmed cell death or apoptosis have also been reported in several studies. It has been shown that overexpression of a C-terminal fragment of PS2 protects neural cells against apoptosis (7) . It was also reported that overexpression of a C-terminal fragment of PS1 delays anti-Fas-induced apoptosis in Jurkat cells (8) . A role for PS1 and PS2 in apoptosis is also supported by studies demonstrating that overexpression of PS1 or PS2 bearing FAD mutations results in increased sensitivity to apoptotic insults (9 -13) . These studies suggest that mutant PS1 and PS2 may be directly involved in neuronal cell death found in the AD brain by regulating the apoptotic cascades. Apoptosis has been implicated as a mechanism of cell death in AD, and the involvement in apoptotic cell death has been reported for all of the three known Alzheimer genes, PS1, PS2, and APP (for review, see Ref. 14) . However, the exact mechanisms by which these molecules are involved in apoptosis are not well understood. Very recently, by using a yeast two-hybrid system, we isolated a novel protein, designated presenilin-associated protein (PSAP), which interacts with the C terminus of PS1 (15) . We now report that PSAP is a proapoptotic molecule that causes apoptotic cell death when it is overexpressed. Our results also indicate that PSAP-induced apoptosis involves caspase activation. Inhibition of caspase activity blocked apoptosis but had no effect on PSAP-induced cytochrome c release from mitochondria, indicating that cytochrome c release is an earlier event in PSAP-induced apoptosis. To explore the biological function of this newly identified molecule, its subcellular localization was also investigated. Our results demonstrate that PSAP is localized in mitochondria. These results indicate that PSAP is a novel mitochondrial protein that may be an important mediator of PS1-regulated apoptotic cell death cascades.
MATERIALS AND METHODS
Reagents-Growth medium, fetal bovine serum, and other supplements were purchased from Invitrogen. The general caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (z-VAD-fmk), was purchased from R&D Systems. Unless stated otherwise, the routine chemicals, proteinase inhibitors, propidium iodide, and bovine serum albumin were obtained from Sigma.
Construction of Expression Vector-For wild type PSAP, PSAP cDNA was amplified with primer pair BHK-PSAPϩ (5Ј-GGATCCAAGCTTG-CCACCATGGCGGG AGCCGGAGCTGGAGCCGG-3Ј) and XbaI-PSAPϪ (5Ј-TCTAGACTCCAGGGCAAA GCATGATCCTG-3Ј). DNA fragments generated by using these primer pairs contained a Kozak sequence, GCCACC (16) , followed by an ATG codon and a XbaI site at the 3Ј end, which allowed insertion of the DNA fragments into the pcDNA3.1/myc-His expression vector (Invitrogen) in frame. The polymerase chain reaction (PCR) product was first cloned into TOPO TM TA cloning vector, pCR ® 2.1-TOPO (Invitrogen), and the fidelity of the DNA sequence was confirmed by DNA sequencing. The inserted DNA was then digested with HindIII/XbaI restriction enzymes and subcloned into pcDNA3.1/myc-His expression vector in frame. Thus, the PSAP was expressed as a myc-tagged polypeptide with the myc-His tag at the C terminus. The plasmid pcDNA3.1/LacZ-myc-His, which expresses LacZ protein with a myc tag, was provided in the pcDNA3.1/myc-His vector package by the vendor (Invitrogen).
To generate the construct expressing PSAP-green fluorescence protein (GFP) fusion protein, PSAP cDNA was amplified with primer pair BHK-PSAPϩ (5Ј-GGATCCAAGCTTGCCACCATGGCGGGAGCCGGA-GCTGGAGCCGG-3Ј)/BamHI-PSAPϪ (5Ј-GGATCCCCTCCAGGGCAA-AGCATGAT-3Ј). The resulting DNA fragment encodes the full-length PSAP in which the stop codon TAA was destroyed and replaced with a BamHI restriction site. The PCR product was cloned into pCR2.1-TOPO vector, and the fidelity of the DNA sequence was confirmed by sequencing. The inserted DNA was then digested with HindIII/BamHI restriction enzymes and subcloned into HindIII/BamHI sites of the pEGFP-N2 vector (Clontech) in frame with the GFP coding sequence. Thus, PSAP was expressed as a fusion protein fused to the N terminus of GFP.
For construction of the plasmid expressing wild type PS1 (PS1wt), PS1 cDNA was amplified by a pair of primers, BHKFPS1ϩ, which encoded the Flag epitope and the N-terminal eight amino acids of PS1 preceded by a HindIII site (GGATCCAAGCTTGCCACCATGGACTAT-AAGGACGACGACGACAAGACAGAGTTACCTGCACCGTTGTC) and BEPS1Ϫ, which is complementary to 3Ј-end of PS1 cDNA and contains a BamHI site (GGATCCGAATTCCTAGATATAAAATTGATGG). The PCR product was first cloned into the pCR2.1-TOPO vector, confirmed for its fidelity by sequencing, and subcloned into HindIII/BamHI sites of the pCDNA3.1 vector (Invitrogen). Thus, PS1 will be expressed with an N-terminal FLAG tag. To generate the D385A mutant PS1(D385A), the flag-tagged PS1wt cDNA in pCR2.1-TOPO vector was amplified with complementary oligonucleotide primers D385A-S (5Ј-AACTTGGATTG-GGAGCTTTCATTTTCTACAGTGT-3Ј) and D385A-AS (5Ј-ACACTGTA-GAAAATGAAAGCTCCCAATCCAAGTT-3Ј), which contain the substitution of a single nucleotide indicated by a bold letter, using the QuikChange ® XL site-directed mutagenesis kit (Stratagene). For mutant PS1(D257A), the flag-tagged PS1wt cDNA in pCR2.1-TOPO vector was amplified with oligonucleotide pairs D257A-S (5Ј-GTGATTTCAGTAT-ATGCTTTAGTGGCTGTTTTGT-3Ј) and D257A-AS (5Ј-ACAAAACAG-CCACTAAAGCATATACTGAAATCAC-3Ј) using the QuikChange ® XL site-directed mutagenesis kit. The fidelity of the sequence has been confirmed by DNA sequencing. The mutant PS1(D385A) and PS1(D257A) cDNAs, in which an aspartate residue was replaced by alanine at position 385 and 257, respectively, were then subcloned into the pcDNA3.1 vector as described above. The double mutant, PS1(D257A/D385A), was constructed by taking advantage of the unique restriction site DraII between codon 257 and codon 385 of the PS1 gene. Both PS1(D257A) and PS1(D385A) in the pcDNA3.1 vector were digested with DraII. The 3Ј end DraII fragment, which contained the D385A mutation from PS1(D385A), was used to replace the 3Ј end DraII fragment of PS1(D257A).
Cell Culture and Transfection-HEK293 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 50 units/ml penicillin, and 50 g/ml streptomycin. Transfection was performed using LipofectAMINE Plus transfection reagent (Invitrogen).
Flow Cytometric Analysis-Cells were transiently transfected with the PSAP expression vector. Twenty-four h after transfection, both floating cells and adherent cells, which were detached by trypsinization, were collected, washed twice with ice-cold phosphate-buffered saline (PBS), and fixed in 90% methanol on ice for 15 min. Cells were collected by centrifugation at 1000 rpm for 2 min, washed twice with cold PBS, suspended in 200 l of PBS, and incubated with RNase A (Sigma, 20 g/ml final concentration) at 37°C for 30 min. The cells were chilled on ice for 10 min, stained with 100 g/ml propidium iodide (Calbiochem) for 1 h, and analyzed by fluorescence-activated cell sorting using an Elite ESP flow cytometer, as described previously (17) .
Differential Interference Contrast and Fluorescence MicroscopyMorphological changes such as cell rounding and membrane blebbing were examined by microscopic inspection of cells under differential interference contrast. Nuclear changes such as chromatin condensation and nuclear fragmentation were analyzed by staining with acridine orange or DAPI. All of the observations, including those of the GFP fluorescence images, were acquired using an Olympus BX-51 fluorescence microscope equipped with the necessary filters and a digital camera.
Nuclear morphological changes of cells transfected with PSAP or LacZ without GFP were examined by acridine orange staining as described previously (18) . Briefly, 24 h after transfection, cells were trypsinized and harvested by centrifugation at 1000 rpm, washed once with PBS, resuspended in 200 l of PBS, and stained with an acridine orange and ethidium bromide dye mixture (final concentration, 10 g/ml for each) immediately before quantification. A minimum of 200 cells/coverslip was scored under a fluorescence microscope for apoptotic morphology.
Nuclear morphological changes of cells transfected with PSAP-GFP were examined by DAPI staining according to the protocol provided by the vender (Roche Molecular Biochemicals). Briefly, cells were plated on poly-L-lysine-coated coverslips. On the next day, cells were transfected with 1 g of plasmid DNA (pPSAP-GFP or pEGFP-N2 as a control) using LipofectAMINE Plus transfection reagent (Invitrogen). Medium was removed 24 h after transfection, and cells were washed once with DAPI-methanol (1 g/ml) and incubated with DAPI-methanol for 15 min at 37°C. After washing once with methanol, coverslips were placed on microslides and the cells were mounted using Vectashield mounting medium for fluorescence (Vector Laboratories, Inc.).
Confocal Immunofluorescence Microscopy-HEK293 cells were plated on poly-L-lysine-coated coverslips. Two days later, the medium was replaced with pre-warmed Dulbecco's modified Eagle's medium containing 25 nM MitoTracker Red (Molecular Probes) and incubated for 15 min to label the mitochondria. For labeling the endogenous PSAP, cells were then fixed with 3.7% formaldehyde in PBS for 20 min, followed by permeabilization with 0.2% Triton X-100 for 4 min. The fixed cells were washed four times with PBS and blocked in 1% bovine serum albumin and 5% normal goat serum. The coverslips were incubated with a rabbit polyclonal anti-PSAP antibody (1:200), which was raised against a peptide corresponding to amino acids 270 -283 of PSAP, for 3 h and rinsed with PBS four times. After incubation with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG secondary antibody (1:200, Santa Cruz Biotechnology) for 1 h, the coverslips were washed with PBS and mounted with Vectashield mounting medium (Vector Laboratories, Inc.). Images were acquired using a confocal laser microscope (Leica TCS SP2).
For cells transfected with PSAP-GFP or GFP alone, the mitochondria were labeled with MitoTracker as described above. The green fluorescence produced by PSAP-GFP or GFP alone was directly observed by confocal laser microscopy.
Mitochondrial Preparation and Cytosolic Extracts-For examination of cytochrome c release, the cytosolic extracts and mitochondria-containing fractions were prepared by permeabilization of cells with streptolysin O using the method described previously by Mosser et al. (19) with slight modification. Briefly, cells (10 6 ) were washed with PBS, collected by centrifugation, and resuspended in 10 l of streptolysin O buffer (20 mM HEPES, pH 7.5, 250 mM sucrose, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, and 1ϫ protease inhibitor mixture) containing 60 units of streptolysin O (Sigma). After incubation at 37°C for 30 min, the permeabilization of cells was monitored by trypan blue staining. At the time when 95% cells were stained, permeabilized cells were pelleted by centrifugation at 16,000 ϫ g for 15 min at 4°C. The supernatant was collected as the cytosolic fraction and subjected to SDS-polyacrylamide gel electrophoresis (10 -14%) followed by Western blotting using anticytochrome c antibody (PharMingen).
For purification of mitochondria, cells were washed once in 10 volumes of Swell Buffer A (10.0 mM Hepes, pH 7.9, 1.5 mM MgCl 2 , 10.0 mM KCl, 0.5 mM dithiothreitol) and pelleted at 200 ϫ g for 5 min at 4°C. The cell pellet was then resuspended in 10 volumes of Swell Buffer A and ruptured with two or three strokes in a Dounce homogenizer using a tight-fitting pestle (pestle B). Sucrose (from a 60% stock solution) was added to a final concentration of 250 mM and centrifuged at 960 ϫ g for 5 min at 4°C to remove unbroken cells, nuclei, and connective tissue fibers. The resulting supernatant was centrifuged at 8,600 ϫ g for 15 min at 4°C to pellet the crude mitochondrial fraction. Mitochondria were further purified on sucrose gradient. The pellet containing the crude mitochondria was resuspended in 4 ml of buffer B (250 mM sucrose, 10 mM Tris-HCl, pH 7.4, and 1 mM EDTA) and layered on top of the sucrose gradients of 35, 40, 43, 46, 50, and 60% of sucrose in 5 ml of TE buffer (10 mM Tris-HCl, pH 7.4, and 1 mM EDTA). After centrif-ugation at 60,000 ϫ g using a Beckman SW 28.1 rotor for 45 min at 4°C, the gradients were fractionated with a 20-gauge/1.5 needle and washed once with three volumes of distilled water at 9600 ϫ g at 4°C for 15 min to dilute the sucrose. The pellet was resuspended in Buffer C (250 mM sucrose, 10 mM Tris-HCl, pH 7.4) and subjected to Western blot analysis.
Immunoprecipitation and Western Blot-For analysis of poly(ADPribose) polymerase (PARP) cleavage, caspase-3 processing, and the ectopic expression of PS1 and PSAP, combined floating and attached cells were lysed by sonication for 20 s on ice in Western blot lysis buffer (50 mM Tris-HCl, pH 6.8, 8 M urea, 5% ␤-mercaptoethanol, 2% SDS, and protease inhibitors). After addition of 4ϫ SDS sample buffer and incubation at 65°C for 15 min, samples were subjected to SDS-polyacrylamide gel (10% for PARP and PSAP or 10 -14% for caspase-3, cytochrome c, and PS1) electrophoresis and transferred to a polyvinylidene fluoride membrane (Immobilon-P, Millipore). The membranes were then probed with monoclonal antibodies against epitope myc (Invitrogen), flag (Sigma), PARP (7D3-6, BD PharMingen), caspase-3 (PharMingen), cytochrome c (PharMingen), anti-PSAP or anti-PS1L and visualized by ECL-Plus (Amersham Biosciences) as described previously (15) .
For immunoprecipitation, cells or purified mitochondria were lysed in immunoprecipitation lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1.0% Triton X-100, and 1.0% Nonidet P-40) supplemented with 1 mM dithiothreitol and protease inhibitor mixture (Roche Molecular Biochemicals) on ice for 30 min. The total cell lysates or lysed mitochondria, obtained as an 18,000 ϫ g supernatant, were incubated with anti-myc (Invitrogen), anti-PSAP, or anti-PS1L and protein ASepharose overnight at 4°C. After washing three times with washing buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% Triton X-100, 5 mM EDTA), the immunoprecipitates were separated by SDS-PAGE and probed with the appropriate antibodies.
RESULTS
In an attempt to establish a cell line stably expressing PSAP, we found that, after transfection with PSAP cDNA, massive cell death occurred in the absence of the selection drugs. This suggested that PSAP could cause cell death and prompted us to examine the nature of cell death caused by overexpression of PSAP.
PSAP Induces Apoptotic Cell Death-Cells can die by either of two major mechanisms: necrosis or apoptosis. Several well established methods can be employed to reveal the observable morphological and biochemical differences between necrosis and apoptosis. We first examined the profile of DNA content using flow cytometry. HEK293 cells were transiently transfected with an expression construct, pcDNA3.1/myc-His/PSAP, which expresses a PSAP-myc fusion protein or control plasmid, pcDNA3.1/myc-His/LacZ, which encodes LacZ with a C-terminal myc tag. Twenty-four h after transfection, the expression of these transgenes was confirmed by Western blot analysis with the anti-myc antibody (Fig. 1A ) and the DNA hypodiploid assays were performed by flow cytometry after DNA staining with propidium iodide. As shown in the upper panel of Fig. 1B , a significant portion of cells transfected with PSAP displayed reduced DNA content, as demonstrated by the appearance of the hypodiploid DNA peak, sub-G 1 peak (indicated as peak B), at the left of the G 1 peak. Cells with lighter DNA staining than that of G 1 cells have been considered apoptotic (20) . The percentage of cells associated with the sub-G 1 peak was 18% in PSAP-transfected cells and less than 2% in LacZ-transfected cells or in cells transfected with vector only.
Early observations of apoptosis revealed that cells entering apoptosis from non-mitotic parts of the cell cycle showed marked and characteristic changes in nuclear shape and organization. We next examined the effect of transient expression of PSAP on the nuclear morphological change in HEK293 cells. As shown in the lower panel of Fig. 1B , fluorescent microscopic analysis by acridine orange staining revealed that a certain number of cells exhibited nuclear condensation and fragmentation, the typical indicator of cells undergoing apoptosis (21).
This nuclear morphology change was at the background level among cells transfected with LacZ cDNA with a myc tag. The percentage of cells with apoptotic morphology was ϳ20% in cells transfected with PSAP and less than 2% in control cells transfected with LacZ cDNA (Fig. 1C ). This observation is consistent with the result of the flow cytometric analysis. A similar result was observed when cell viability was determined by CellTiter 96 AQueous Assay (Promega, data not shown). The cytotoxicity of PSAP was not caused by the myc tag that was expressed as a part of the fusion protein, nor was it the result of a toxic effect of our overexpression system, because overexpression of myc-tagged LacZ protein did not induce apoptotic DNA loss or nuclear morphological change. The percentage of apoptotic cells observed (ϳ20%) may reflect the limitation of the efficiency of the transient transfection method used in our experiments. The transfection efficiency was determined to be 20 -30% by transfecting cells with pCMV-␤Gal followed by a colorimetric assay (data not shown).
Controlled fragmentation of genomic DNA is another hallmark of apoptosis. We further examined PSAP-induced apoptosis using a DNA laddering assay. As shown in Fig. 1D , analysis of DNA from PSAP-transfected cells demonstrated the generation of the typical nucleosomal-sized ladders of DNA fragments (lane 3). There was no detectable DNA laddering after electrophoresis of DNA from cells transfected with a negative control plasmid expressing myc-tagged LacZ protein (lane 2).
To further confirm that the apoptotic cell death is caused by overexpression of PSAP, cells were transfected with a plasmid that expresses PSAP-GFP fusion protein. The expression of PSAP-GFP and the morphological change on individual cells were monitored as described under "Materials and Methods." The expression of PSAP-GFP and GFP alone in transfected cells was also determined by Western blot analysis using a GFP-specific antibody from Clontech (data not shown). As shown in Fig. 2 , only the cells expressing PSAP-GFP, but not the cells transfected with GFP alone, displayed blebbed membranes, condensed chromatin, and fragmented nuclei as indicated by arrowheads in panels A, B, and C of Fig. 2 . This one-to-one correlation holds for all of the microscopic fields observed in all of three replicated experiments. These results strongly argue that only, and all of, the cells transfected with PSAP undergo apoptosis.
Because cleavage of the death substrate, PARP, by activated caspase is another prominent indicator of apoptosis (22), we also performed a time-course experiment to analyze the cleavage of PARP upon overexpression of PSAP. HEK293 cells were transfected with PSAP. At various time points, equal numbers of cells were harvested and the cleavage of PARP and the expression of PSAP were analyzed by Western blot. As shown in the top panel of Fig. 3, 8 h after transfection with PSAP, the 85-kDa fragment of PARP, which is a characteristic of apoptosis, became detectable. Similar results were also observed in HeLa cells and the human neuroblastoma cell line M17 (data not shown). The maximum cleavage of PARP was observed within 24 h after transfection. The time course of PARP cleavage is in good agreement with the time course of PSAP expression (middle panel of Fig. 3) . A similar time course was also observed by flow cytometric analysis; the proportion of cells displaying sub-G 1 DNA content reached a peak at 24 h after transfection (data not shown).
PSAP-induced Apoptosis Involves Caspase Activation-The key effectors of apoptotic cell death are caspases, a family of cysteine proteases activated by proteolytic processing upon induction of apoptosis (23) . To determine whether PSAP-induced apoptosis involves caspase activation, HEK293 cells were transfected with plasmids expressing PSAP or LacZ and incubated in medium with or without the general caspase inhibitor z-VAD-fmk (100 M, "Material and Methods"). z-VADfmk is a specific tetrapeptide pseudosubstrate for several caspases, including caspase-3, which could irreversibly block the caspase proteolytic cascade (24) . Twenty-four h after transfection, expression of myc-targeted PSAP and LacZ was detected by anti-myc antibody (panel A of . Taken together, these data suggest that PSAP-induced cell death was mediated by caspase activation. As caspase-3 is one of the main effector caspases and is activated in response to both intracellular and extracellular death signals, its activation also provided additional evidence that overexpression of PSAP triggers an apoptotic cascade.
PSAP Induces Cytochrome c Release Independent of Caspase Activation-There are two major signaling pathways of caspase activation and apoptosis: the death receptor pathway and the death receptor-independent or mitochondria-dependent pathway. In the death receptor pathway, such as FasL-induced apoptosis in type I cells, the initiator caspase-8 is activated upon binding of FasL to the death receptor Fas. Subsequently, the activated caspase-8 can directly activate downstream caspase-3, the executor caspase, resulting in apoptosis (25) . In some case, such as type II cells, cytochrome c may also be released from mitochondria in the death receptor-dependent pathway to amplify the death signals. In this case, cytochrome c is released via caspase-8-activated Bid and is therefore dependent on caspase activity (26, 27) . In contrast, in the mitochondria-dependent pathway many other apoptotic stimuli, such as reactive oxidant intermediates, cause damage to mitochondria and release of cytochrome c. Once in the cytosol, cytochrome c is bound by Apaf-1, which also binds caspase-9 and dATP to form the apoptosome complex, resulting in the activation of caspase-9 and, subsequently, downstream caspases, such as caspase-3 (28) . To determine the nature of PSAP-induced apoptosis, we therefore examined whether PSAP is capable of regulating the release of cytochrome c from mitochondria. The cytosolic fraction was prepared by permeabilization of cells with streptolysin O as described under "Materials and Methods." Cytochrome c redistribution was determined by Western blot analysis using a cytochrome c-specific antibody. As shown in panel D of Fig. 4 , cytochrome c was detected in the cytosolic fraction prepared from cells transfected with PSAP (lanes 2 and 3), but not from cells transfected with LacZ (lane 1) or untransfected cells (lane 4). This membrane was also re-probed by an antibody against the mitochondrial protein cytochrome oxidase subunit I (Cox I), and no Cox I was detected, indicating there was no contamination of mitochondria in these cytosolic fractions. The same results were observed when the cytosolic fraction was prepared using a Dounce homogenizer as described previously (29) panel D) , indicating that the release of cytochrome c from mitochondria was independent of caspase activity. This result suggests that cytochrome c release is an early event in PSAP-induced apoptosis and is not a consequence of caspase activation.
PSAP Is Localized in Mitochondria-To better understand the biological function(s) of PSAP, we determined its subcellular localization. We first performed subcellular fractionation of HEK293 cells. Cell lysates were fractionated by sucrose gradient centrifugation, as described under "Materials and Methods," and subjected to Western blot analysis using a polyclonal antibody directed against a peptide corresponding to amino acids 270 -283 of PSAP. The specificity of this antibody was fully characterized (Fig. 5A ). Using this PSAP-specific antibody, we found PSAP exclusively in the mitochondria-enriched fraction as shown in the top panel of Fig. 5B (lanes 3 and 4) . The samples obtained from this sucrose gradient centrifugation were also assayed for cytochrome c (second panel of Fig. 5B ) and CoxI (third panel of Fig. 5B ) by Western blot using a cytochrome c-or a CoxI-specific antibody (PharMingen or Molecular Probes), respectively. Both mitochondrial proteins were detected solely in the same subcellular fraction (lanes 3 and 4) in which PSAP was detected. These data suggest that PSAP is localized to the mitochondria. The same subcellular distribution of PSAP was also observed in cells of neuronal origin, such as M17 cells (30) and N2a cells (31) . Data shown in the fourth and fifth panels of Fig. 5B represent the results obtained from the subcellular fractionation of M17 cells.
To test further the mitochondrial localization of PSAP, immunofluorescence of intact cells was performed using the same polyclonal antibody. As shown in Fig. 6 , PSAP immunofluorescence displayed a vermiform pattern throughout the cytoplasm of cells with no diffuse staining (Fig. 6, panel A) . These structures resembled mitochondria with regard to their punctate subcellular distribution and threadlike appearance (32) . In addition, the same cells were labeled with MitoTracker Red (Molecular Probes), which is sequestered in mitochondria and fluoresces red after oxidation (Fig. 6, panel B) . The PSAP immunofluorescence overlapped exactly the mitochondria stained by MitoTracker Red, as revealed by double staining confocal microscopy (Fig. 6, panel C) . The co-segregation of PSAP with two distinct mitochondrial proteins in subcellular fractionation and the colocalization of PSAP with a mitochondria-selective dye in immunofluorescence microscopy strongly FIG. 5 . PSAP co-fractionates with mitochondrial proteins. A, to determine the specificity of the anti-PSAP antibody, lysates of cells transfected with myc-tagged PSAP were subjected to wide-well slab gel (10%) electrophoresis and transferred to a membrane. The membrane was sliced into two pieces along the central line of the sample loading well. One piece was probed with anti-myc, which revealed one band (lane 1); the other piece was probed with anti-PSAP antibody, which revealed two bands (lane 2). The upper band detected by anti-PSAP is apparently the same band detected by anti-myc, which is the ectopic myc-tagged PSAP. The lower band should be endogenous PSAP. Because the ectopic recombinant PSAP was expressed as a fusion protein with a myc and poly-His tag at the C terminus, it was detected as a higher molecular weight band in comparison with the endogenous counterpart. To further determine the specificity of this antibody, the cell lysate was immunoprecipitated with anti-PSAP or with anti-myc antibody and probed with anti-myc or with anti-PSAP. In the anti-PSAPimmunoprecipitate, two bands (lane 3) were detected by anti-PSAP and one band (lane 4) was detected with anti-myc, which is apparently the same as the upper band in lane 3. As expected, both anti-PSAP and anti-myc detected one band in the anti-myc immunoprecipitate (lanes 5 and 6). In lane 3, because the same antibody was used for both immunoprecipitation and detection, some nonspecific bands were detected above the PSAP bands. No specific band was detected using preimmune serum or anti-PSAP presaturated with the peptide, which was used to raise this antibody (data not shown). B, subcellular fractionation was carried out as described under "Materials and Methods." Lanes 1-6 are the six fractions obtained from sucrose gradient centrifugation corresponding to densities 1.151, 1.176, 1.192, 1.207, 1.229, and 1.286 mg/ml, respectively. The mitochondrial proteins, cytochrome c (cyt.c, second and fifth panels) and CoxI (third panel) were recovered in fractions 3 and 4, at densities of 1.17 and 1.21 g/ml (lanes 3 and 4) , which contain mitochondria (61) . PSAP was also detected in fractions 3 and 4 (top and fourth panels). Lane 7 is the nuclear fraction. Lane 8 is the total cell lysate.
suggest that PSAP is localized to mitochondria. A similar subcellular distribution of PSAP was also observed in other types of cells, such as N2a and HeLa cells (data not shown).
Next, we examined whether the ectopic overexpression has any effect on PSAP subcellular distribution. HEK293 cells were transfected with constructs expressing PSAP-GFP or GFP alone as described in Fig. 2 . Six h after transfection, before the mitochondria begin to cluster, which occurs in the early stage of apoptosis, confocal microscopy was performed. As shown in panel D of Fig. 6 , the green fluorescence in PSAP-GFP cells was distributed to punctate structures within the cytosolic compartment. Similar structures were observed when the same cell was stained with MitoTracker Red (Fig. 6, panel E) . In contrast, green fluorescence in GFP cells was homogeneously distributed within the cells without localization to specific structures (Fig.  6, panel F) . Taken together, our data demonstrated that both endogenous and ectopic PSAP were localized to the mitochondria. After we reported the molecular cloning of PSAP, more nucleotide sequence information became available from the GenBank TM data base. Performing anew a BLAST search of GenBank TM revealed that PSAP is homologous to mitochondrial carrier proteins (Fig. 7) , a family of proteins that reside in the mitochondria and catalyze the transport of metabolites across the inner mitochondrial membrane (33) . As shown in Fig. 7 , there are two regions (amino acids 61-159 and 188 -248) in PSAP that share homology with the consensus sequence of mitochondrial carrier proteins. Like other mitochondrial carrier proteins, sequence analysis also revealed that PSAP does not contain the signal peptide that is required for most other mitochondrial precursors to localize to mitochondria (34, 35) . The finding that PSAP is homologous to mitochondrial carrier proteins provides additional support for the mitochondrial localization of PSAP.
PSAP Interacts with PS1 in Mitochondria-As PSAP was originally identified as a PS1-interacting protein and PS1 was also recently detected in the mitochondria (36), we conducted an experiment to determine by co-immunoprecipitation whether PSAP and PS1 form a complex in mitochondria. 293 cells were transfected with a PS1-expressing plasmid. Twentyfour h after transfection, cells were harvested and subcellular fractionation was performed as described under "Materials and Methods". Both total cell lysates and the mitochondria-enriched fraction were subjected to immunoprecipitation. As shown in Fig. 8, PS1 was co-immunoprecipitated with PSAP by anti-PSAP antibody from both total cell lysates (lane 1) and the mitochondria-enriched fraction (lane 5).
PSAP-induced Apoptosis Was Weakly Inhibited by Co-expression of PS1 in a Transient
Transfection System-To determine the effect of PS1 on PSAP-induced apoptosis, we created several constructs expressing wild type PS1 or mutant PS1, which contains the substitution of alanine for aspartate residues at codon 257 (D257A) or 385 (D385A) or at both positions (D257A/ D385A). These two PS1 mutants were tested because they have been shown to dramatically affect the biological function of PS1. Mutation of either of the two conserved aspartate residues has been found to inhibit the endoproteolytic cleavage of PS1 and reduce the intramembranous cleavage of APP and Notch proteins (37, 38) . Both PS1(D257A) and PS1(D385A) mutants were originally reported to reduce A␤ production and increase the accumulation of C-terminal fragments of APP (37), whereas others showed that PS1(D257A) has no significant effect on A␤ production (39, 40) . Cells were co-transfected with both PSAP and one of the PS1-expressing constructs, and the effect of PS1 on PSAP-induced apoptosis was determined by PARP cleavage. As controls, cells were also co-transfected with LacZ and one of the PS1-expressing vectors. As shown in Fig. 9A , cleavage of PARP was detected in all of the cells transfected with PSAP or PSAP plus PS1 (lanes 6 -10 of the middle panel of Fig. 9A ), but not in cells transfected with LacZ or LacZ plus PS1 (lanes 1-5 of the middle panel of Fig. 9A ), indicating that neither wild type PS1 nor mutant PS1 cause apoptosis by themselves. On the other hand, a weak inhibitory effect of PS1 on PSAPinduced apoptosis was observed in the co-transfection of cells with both PSAP and PS1 as determined by the cleavage of PARP (lanes 6 -10 of the middle panel of Fig. 9A ). As shown in Fig. 9B , the results of quantitative analysis revealed that PSAP-induced apoptosis was inhibited by 15-18% by co-expression of PS1 and no significant differences were observed between wild type PS1 and the mutant PS1 tested.
DISCUSSION
In a previous study, we reported the molecular cloning of a presenilin-associated protein, PSAP. The results of our current work reveal that overexpression of this novel protein causes apoptotic cell death. The apoptotic activity of PSAP was determined by multiple approaches, including assays for characteristic nuclear morphological changes, DNA fragmentation, and the cleavage of the death substrate, PARP. Our experiments also clearly demonstrated that PSAP-induced apoptosis involves caspase activation and cytochrome c release from mitochondria and that PSAP-induced cytochrome c release is upstream of caspase activation. In addition, PSAP immunofluorescence colocalized with a mitochondrion- selective dye and co-segregated with two distinct mitochondrial proteins in subcellular fractionation. Together, these results identify PSAP as a novel mitochondrial protein as well as a proapoptotic molecule.
Two major signaling pathways of apoptosis have been identified: the death receptor pathway and the mitochondrial pathway (26) . Many apoptotic stimuli, such as FasL or tumor necrosis factor-␣, induce activation of the initiator caspase-8 upon binding to a death receptor, such as CD95 (Fas/APO-1) or tumor necrosis factor receptor-1 or -2. Subsequently, the activated caspase-8 activates downstream caspases, including caspase-3, the executor caspase, leading to apoptotic cell death (for review, see Refs. 27 and 41). In contrast to death receptormediated apoptosis, there are various death-inducing signals, such as excess reactive oxidant intermediates, decreases in mitochondrial redox status, and increases in intracellular calcium, which can trigger mitochondria to release several apoptogenic factors, such as cytochrome c and apoptosis-inducing factor, which are usually present in the intermembrane space of these organelles. Specifically, the release of cytochrome c from mitochondria is considered a key early step in the mitochondrion-dependent apoptotic process (42, 43) . Recently, cross-talk between these two apoptosis pathways has been noted, and this cross-talk is likely mediated by caspase-8-activated Bid, a proapoptotic member of the Bcl-2 family proteins. This cross-talk has been found to be essential in some cases to amplify the weak signals mediated by the death receptor. Thus, mitochondria play an important role in both pathways (for review, see Refs. 26 and 27) . It is notable that PSAP-induced cytochrome c redistribution is independent of caspase activity, suggesting that cytochrome c release from mitochondria is upstream of caspase activation, and is an early event in PSAPinduced apoptosis, suggesting that PSAP induces apoptosis via a mitochondria-dependent pathway. An additional indicator that overexpression of PSAP caused mitochondrial damage is suggested by the disappearance of the PSAP-GFP fluorescence signal from the peripheral region of the cytoplasm and its aggregation around nuclei after prolonged periods following PSAP-GFP transfection (compare panel B of Fig. 2 with panel  D of Fig. 6 ). Because PSAP is localized to mitochondria, this result suggests that overexpression of PSAP induces eventual clustering of mitochondria. The same morphological change was also observed as an early stage of tBID-induced apoptosis (44) . As a proapoptotic molecule, its mitochondrial localization puts PSAP in an important position in regulating mitochondriondependent cell death.
In an attempt to understand the molecular basis by which (lanes 6 -10) of A. Using the program NIH Image 1.61, the density of the 116-kDa full-length PARP and the 85-kDa cleavage fragment were measured and the ratios of 85 kDa/(85 kDa ϩ 116 kDa) were calculated. The ratio of 85 kDa/(85 kDa ϩ 116 kDa) in cells transfected with PSAP and pcDNA3.1 empty vector was set at 100% of the apoptotic activity of PSAP to calculate the inhibitory effect of PS1 on PSAP-induced apoptosis. These data represent the results obtained from three independent experiments. presenilin proteins are involved in apoptosis, it has been shown that PS1 interacts with Bcl-2 (45), and that both PS1 and PS2 interact with Bcl-X L (46) . Based on these observations, it has been suggested that PS1 may play a role in apoptosis by providing a part of a macromolecular complex that contains Bcl-2 family proteins (45) . Members of the Bcl-2 family are functionally classified into two groups. Both Bcl-2 and Bcl-X L are antiapoptotic members of the Bcl-2 family protein. In contrast, the other group, comprising Bax and its related proteins, promotes apoptosis. It has been reported that overexpression of Bax induces apoptotic cell death without another death stimulus (47, 48) . By comparing the amino acid sequence of PSAP with that of members of Bcl-2 family, certain key residues were noted. The Gly-Asp pairs, which are conserved in the BH3 domain of the Bcl-2 family proteins, were found in both N-and C-terminal and middle regions of PSAP. Because no significant homology was found in the regions flanking the Gly-Asp residues that compose the core of the BH3 domain (49) , it may be too early to conclude that PSAP is related to the Bax group of proteins without more biochemical evidence. PSAP may represent a new class of apoptotic protein.
PS1 is apparently a multifunctional protein and has been found in various subcellular compartments. Presenilin proteins were predominantly localized to the endoplasmic reticulum and, to a lesser extent, the Golgi apparatus and perinuclear region (50, 51) . PS1 is also found in plasma membrane (52) and regulates cell-cell adhesion (53) or participates in the ␥-secretase-like proteolysis of Notch protein (38) . In addition, the presence of small amounts of presenilin in other organelles is likely, as suggested by punctate staining (54, 55) . In support of this speculation, it has been demonstrated very recently that PS1 can also be detected in mitochondria, using immunoblot and immunoelectron microscope analyses of tissue sections and subcellular fractionation of rat brain and liver (36) . Our data show that a PSAP-PS1 complex can be co-immunoprecipitated from mitochondria, suggesting the interaction between PSAP and PS1 in mitochondria. The identification of PSAP as a proapoptotic mitochondrial molecule suggests a new view of the role of PS1 in regulating apoptosis observed in Alzheimer's disease. The specific interaction of PSAP with PS1, but not PS2 (15) , implies that PSAP is involved in a particular apoptotic pathway that only associates with PS1, but this remains to be investigated. Despite the fact that PS1 and PS2 share many pathological and biological functions, specifically in abnormal A␤ production (56) , accumulating evidence suggests that PS1 and PS2 have distinct roles in apoptotic cell death. The apoptotic activity of PS2 was first reported in a study showing that overexpression of PS2 in nerve growth factor-differentiated PC12 cells increased apoptosis induced by trophic factor withdrawal or ␤-amyloid and a PS2 mutation enhanced the basal apoptotic activity (13) . A very recent study suggested that the wild type and mutant PS2 might induce a p53-dependent apoptotic cascade and down-regulate PS1 expression (57) . In contrast, wild type PS1 has been shown to have protective effect against apoptosis. It has been shown that overexpression of PS1 protects against apoptosis of cortical neurons induced by etoposide or staurosporine (58) . Furthermore, it was shown that suppression of PS1 expression by antisense increased apoptosis of NT2 cells (59) . Similarly, a very recent study has also reported that PS1 protects against neuronal apoptosis caused by its interacting protein, PAG (60) . To determine the effect of PS1 on PSAP-induced apoptosis, we have co-transfected 293 cells with PSAP and PS1. Our results revealed that co-expression of PS1 did slightly inhibit PSAP-induced apoptosis in a transient transfection model. No significant differences were observed between wild type PS1 and the PS1 mutant in which the critical aspartates were substituted by alanine, suggesting that these mutations have little effect on PSAP-induced apoptosis in comparison with the dramatic effect of these mutations on A␤ production. The protective effect of PS1 against PSAPinduced apoptosis is slightly weaker in comparison with that reported against other apoptotic stimuli (58, 60) . This difference may be due to differences in cells used or methods employed for delivering foreign DNA. In both of the previous studies, neuronal cells have been used and the foreign DNA has been delivered either by viral vectors (58) or by microinjection (60) . Alternatively, this difference may be simply because the strong apoptotic activity of PSAP overcame the protective effect of PS1. Alternatively, PSAP may be downstream of PS1 in an apoptosis pathway that regulates PSAP-induced apoptosis. Therefore, apoptosis induced by overexpression of a downstream element, in this case, PSAP, would be less affected by the upstream regulator, PS1. Further determination of how PS1 regulates PSAP-mediated apoptosis is awaiting the identification of the particular apoptotic pathway mediated by PS1 and PSAP.
